Author/Authors :
Michael L. Curtin، نويسنده , , Robin R. Frey، نويسنده , , H. Robin Heyman، نويسنده , , Kathy A Sarris، نويسنده , , Douglas H. Steinman، نويسنده , , James H Holmes، نويسنده , , Peter F Bousquet، نويسنده , , George A Cunha، نويسنده , , Maria D Moskey، نويسنده , , Asma A Ahmed، نويسنده , , Lori J. Pease، نويسنده , , Keith B. Glaser، نويسنده , , Kent D Stewart، نويسنده , , Steven K. Davidsen، نويسنده , , Michael R. Michaelides، نويسنده ,
Abstract :
A series of substituted isoindolinone ureas was prepared and evaluated for enzymatic and cellular inhibition of KDR kinase activity. Several of these analogs, such as 14c, are potent inhibitors of KDR both enzymatically (<50 nM) and cellularly ( 100 nM). A 3D KDR/CDK2/MAP kinase overlay model with several structurally related tyrosine kinase inhibitors was used to predict the binding interactions of the isoindolinone ureas with the KDR active site.
Keywords :
KDR kinase , Isoindolinone , VEGF , Urea.* Corresponding author. Tel.: +1-847-9380463 , fax: +1-847-9355165 , e-mail: mike.curtin@abbott.com
